{"id":20135497,"updated":"2023-07-28T07:10:13Z","additionalIndexing":"15;2841;Bundesamt für Gesundheit;pharmazeutische Industrie;Arzneikosten;Preisunterschied;Forschungspolitik;Forschungsförderung;medizinische Forschung;Wirtschaftsstandort Schweiz;Medikament;Wechselkurs","affairType":{"abbreviation":"Fra.","id":14,"name":"Fragestunde. Frage"},"author":{"councillor":{"code":3011,"gender":"m","id":4099,"name":"Lehmann Markus","officialDenomination":"Lehmann"},"faction":{"abbreviation":"Fraktion CE","code":"M-E","id":3,"name":"Fraktion CVP-EVP"},"type":"author"},"deposit":{"council":{"abbreviation":"NR","id":1,"name":"Nationalrat","type":"N"},"date":"2013-11-27T00:00:00Z","legislativePeriod":49,"session":"4911"},"descriptors":[{"key":"L04K16020204","name":"Forschungsförderung","type":1},{"key":"L03K160202","name":"Forschungspolitik","type":1},{"key":"L03K010503","name":"pharmazeutische Industrie","type":1},{"key":"L05K0704030111","name":"Wirtschaftsstandort Schweiz","type":1},{"key":"L05K0105050101","name":"Arzneikosten","type":1},{"key":"L05K0105030102","name":"Medikament","type":2},{"key":"L04K11030304","name":"Wechselkurs","type":2},{"key":"L04K11050311","name":"Preisunterschied","type":2},{"key":"L04K08040103","name":"Bundesamt für Gesundheit","type":2},{"key":"L04K01050512","name":"medizinische Forschung","type":2}],"drafts":[{"consultation":{"resolutions":[]},"federalCouncilProposal":{},"index":0,"links":[],"preConsultations":[],"references":[],"relatedDepartments":[{"abbreviation":"EDI","id":4,"name":"Departement des Innern","leading":true}],"states":[{"date":"\/Date(1385506800000+0100)\/","id":24,"name":"Im Rat noch nicht behandelt"},{"date":"\/Date(1385938800000+0100)\/","id":229,"name":"Erledigt"}],"texts":[]}],"language":"de","relatedAffairs":[],"roles":[{"councillor":{"code":3011,"gender":"m","id":4099,"name":"Lehmann Markus","officialDenomination":"Lehmann"},"faction":{"abbreviation":"Fraktion CE","code":"M-E","id":3,"name":"Fraktion CVP-EVP"},"type":"author"}],"shortId":"13.5497","state":{"id":229,"name":"Erledigt","doneKey":"0","newKey":0},"texts":[{"type":{"id":5,"name":"Eingereichter Text"},"value":"

Im Dezember 2011 hat das Parlament dem Bundesrat mit der Motion 11.3910 den Auftrag erteilt, innert sechs Monaten einen Masterplan zur Stärkung des Forschungs- und Pharmastandorts Schweiz vorzulegen.<\/p>

1. Was kann der Bundesrat zum aktuellen Stand des Masterplans sagen?<\/p>

2. Wann liegt der Masterplan dem Parlament endlich vor?<\/p>"},{"type":{"id":1,"name":"Titel des Geschäftes"},"value":"Wie weiter mit der Motion 11.3910?"}],"title":"Wie weiter mit der Motion 11.3910?"}